These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
470 related articles for article (PubMed ID: 21272603)
1. Exploring the vaccine potential of Dec-205 targeting in Mycobacterium tuberculosis infection in mice. Stylianou E; Pepponi I; van Dolleweerd CJ; Paul MJ; Ma JK; Reljic R Vaccine; 2011 Mar; 29(12):2279-86. PubMed ID: 21272603 [TBL] [Abstract][Full Text] [Related]
2. Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice. Stylianou E; Diogo GR; Pepponi I; van Dolleweerd C; Arias MA; Locht C; Rider CC; Sibley L; Cutting SM; Loxley A; Ma JK; Reljic R Eur J Immunol; 2014 Feb; 44(2):440-9. PubMed ID: 24214530 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice. Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695 [TBL] [Abstract][Full Text] [Related]
4. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice. Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590 [TBL] [Abstract][Full Text] [Related]
5. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice. Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772 [TBL] [Abstract][Full Text] [Related]
6. Targeting Velasquez LN; Stüve P; Gentilini MV; Swallow M; Bartel J; Lycke NY; Barkan D; Martina M; Lujan HD; Kalay H; van Kooyk Y; Sparwasser TD; Berod L Front Immunol; 2018; 9():471. PubMed ID: 29662482 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of immune response to a DNA vaccine against Mycobacterium tuberculosis Ag85B by incorporation of an autophagy inducing system. Meerak J; Wanichwecharungruang SP; Palaga T Vaccine; 2013 Jan; 31(5):784-90. PubMed ID: 23228812 [TBL] [Abstract][Full Text] [Related]
8. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis. Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584 [TBL] [Abstract][Full Text] [Related]
9. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice. Li W; Li M; Deng G; Zhao L; Liu X; Wang Y Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477 [TBL] [Abstract][Full Text] [Related]
10. Immune responses and protective efficacy of the gene vaccine expressing Ag85B and ESAT6 fusion protein from Mycobacterium tuberculosis. Chang-hong S; Xiao-wu W; Hai Z; Ting-fen Z; Li-Mei W; Zhi-kai X DNA Cell Biol; 2008 Apr; 27(4):199-207. PubMed ID: 18163878 [TBL] [Abstract][Full Text] [Related]
11. Cellular and humoral immunogenicity of recombinant Mycobacterium smegmatis expressing Ag85B epitopes in mice. Kadir NA; Sarmiento ME; Acosta A; Norazmi MN Int J Mycobacteriol; 2016 Mar; 5(1):7-13. PubMed ID: 26927984 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice. Yuan W; Dong N; Zhang L; Liu J; Lin S; Xiang Z; Qiao H; Tong W; Qin C Vaccine; 2012 Mar; 30(14):2490-7. PubMed ID: 21704108 [TBL] [Abstract][Full Text] [Related]
13. DNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection. Dalmia N; Klimstra WB; Mason C; Ramsay AJ PLoS One; 2015; 10(8):e0136635. PubMed ID: 26317509 [TBL] [Abstract][Full Text] [Related]
14. Subcutaneous administration of modified vaccinia virus Ankara expressing an Ag85B-ESAT6 fusion protein, but not an adenovirus-based vaccine, protects mice against intravenous challenge with Mycobacterium tuberculosis. You Q; Jiang C; Wu Y; Yu X; Chen Y; Zhang X; Wei W; Wang Y; Tang Z; Jiang D; Wu Y; Wang C; Meng X; Zhao X; Kong W Scand J Immunol; 2012 Jan; 75(1):77-84. PubMed ID: 21916923 [TBL] [Abstract][Full Text] [Related]
15. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice. Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020 [TBL] [Abstract][Full Text] [Related]
16. Characterisation of a live Salmonella vaccine stably expressing the Mycobacterium tuberculosis Ag85B-ESAT6 fusion protein. Hall LJ; Clare S; Pickard D; Clark SO; Kelly DL; El Ghany MA; Hale C; Dietrich J; Andersen P; Marsh PD; Dougan G Vaccine; 2009 Nov; 27(49):6894-904. PubMed ID: 19755145 [TBL] [Abstract][Full Text] [Related]
17. A novel dendritic cell-targeted lentiviral vector, encoding Ag85A-ESAT6 fusion gene of Mycobacterium tuberculosis, could elicit potent cell-mediated immune responses in mice. Shakouri M; Moazzeni SM; Ghanei M; Arashkia A; Etemadzadeh MH; Azadmanesh K Mol Immunol; 2016 Jul; 75():101-11. PubMed ID: 27267270 [TBL] [Abstract][Full Text] [Related]
18. Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis. Ballester M; Nembrini C; Dhar N; de Titta A; de Piano C; Pasquier M; Simeoni E; van der Vlies AJ; McKinney JD; Hubbell JA; Swartz MA Vaccine; 2011 Sep; 29(40):6959-66. PubMed ID: 21787826 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis. Tang C; Yamada H; Shibata K; Maeda N; Yoshida S; Wajjwalku W; Ohara N; Yamada T; Kinoshita T; Yoshikai Y J Infect Dis; 2008 May; 197(9):1263-74. PubMed ID: 18422438 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein. Deng YH; He HY; Zhang FJ Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]